Skip to main content
Caplight Logo









AUSTRAL Dx

AUSTRAL Dx

Private
ParisHealthcare & Life Scienceshttps://www.australdx.fr/

Last Round

Seed

Jul 24, 2025

Est. Valuation

$7.37M

Total Funding Raised

$4.74M

Company Overview

AUSTRAL Dx is a diagnostic equipment company that develops a device utilizing non-invasive, airborne ultrasound analysis to screen, diagnose, and monitor cardiac and pulmonary conditions.

Sector

Healthcare & Life Sciences

Verticals

Medical Imaging, Medical Devices, Medical AI, Sensors

Business Model

B2B

Customer Profile

Hardware Sales, Hardware + Subscription

AI Layer

Application

Keywords

airborne ultrasoundmedical imagingcardiopulmonary diagnosispoint of care ultrasoundPOCUScontactless monitoringmedical AIAI diagnosticsclinical triageremote patient monitoringRPMemergency medicinedigital healthmedtechedge AI

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

AUSTRAL Dx Comparables

Compare AUSTRAL Dx with similar companies based on industry and business-model similarity.

AUSTRAL Dx comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Acorai
78%
EchoNous
67%
Clarius Mobile Health
65%

AUSTRAL Dx Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedJul 24, 2025
CrowdfundingJun 2, 2025

AUSTRAL Dx Investors

Notable investors and investment history

AUSTRAL Dx investors
InvestorRounds
Kima VenturesCrowdfunding, Seed
Super CapitalSeed
Région Sud InvestissementSeed
Paris Business AngelsCrowdfunding, Seed
Angels SantéCrowdfunding, Seed
Better AngleCrowdfunding, Seed
iXcoreCrowdfunding, Seed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Mar 1, 2026

    Grew 25% QoQ, from 12 to 15 employees.

  • Oct 16, 2025

    Grew 33% QoQ from 9 to 12 employees.

AUSTRAL Dx Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

AUSTRAL Dx Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about AUSTRAL Dx's valuation, stock price, and market status.

Firmographic Details

HeadquartersParis
Employee Range17
Year Founded2021
Last FundingJul 24, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?